Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 3.20m |
Free float | 3.18m |
P/E (TTM) | -- |
Market cap | 1.54m USD |
EPS (TTM) | -10.68 USD |
Data delayed at least 15 minutes, as of Aug 18 2023 07:10 BST.
More ▼
Announcements
- Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
- Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
- Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
- Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
- Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
- Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
- Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
- Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
- Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
More ▼